【24h】

Commentary to malmborg and ploeger

机译:对Malmborg和Ploeger的评论

获取原文
获取原文并翻译 | 示例
           

摘要

I was involved in the current pro-drug project at an early stage, and also acknowledged by authors and former colleagues Malmborg and Ploeger for my input on rate constants and assay selection. Apparently, the project changed direction and prediction methodology after my involvement I was not aware of the new strategy and publication work until the time of publication.It is a good piece of work. However, I found that their Eq. (3) is not applicable for prediction of intestinal k_a as presented in their physiologically-based pharmacokinetic model, and this is likely to have a non-negligible impact on the predictions, outcome, validity and usefulness. In such a set-up Eq. (2) applies. In comparison, the used Eq. (3) gives at least 3-fold higher k_a-values than the proposed Eq. (2). The difference is most pronounced for highly permeable compounds.
机译:我在早期阶段参与了目前的亲药项目,也应由作者和前同事Malmborg和Ploeger承认我对速率常数和测定选择的输入。 显然,在我的参与后,项目改变了方向和预测方法,我并不了解新的战略和出版物,直到出版时间。它是一项很好的工作。 但是,我发现他们的eq。 (3)不适用于预测其生理学上基于药代动力学模型的肠K_A,这可能对预测,结果,有效性和有用性具有不可忽略的影响。 在这样的设置方面。 (2)适用。 相比之下,使用的eq。 (3)给出比提出的等式更高的K_A值至少3倍。 (2)。 对于高渗透性化合物,差异最为明显。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号